GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » Earnings Yield (Joel Greenblatt) %

YSB (HKSE:09885) Earnings Yield (Joel Greenblatt) % : -101.01% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is YSB Earnings Yield (Joel Greenblatt) %?

YSB's Enterprise Value for the quarter that ended in Dec. 2023 was HK$3,467 Mil. YSB's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-3,500 Mil. YSB's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2023 was -101.01%.

The historical rank and industry rank for YSB's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

HKSE:09885' s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -518.07   Med: -52.58   Max: -4.44
Current: -101.01

During the past 4 years, the highest Earnings Yield (Joel Greenblatt) of YSB was -4.44%. The lowest was -518.07%. And the median was -52.58%.

HKSE:09885's Earnings Yield (Joel Greenblatt) % is ranked worse than
94.67% of 694 companies
in the Healthcare Providers & Services industry
Industry Median: 2.58 vs HKSE:09885: -101.01

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. YSB's Forward Rate of Return (Yacktman) % for the quarter that ended in Dec. 2023 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


YSB Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for YSB's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YSB Earnings Yield (Joel Greenblatt) % Chart

YSB Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Earnings Yield (Joel Greenblatt) %
- - - -101.01

YSB Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial - - - - -101.01

Competitive Comparison of YSB's Earnings Yield (Joel Greenblatt) %

For the Pharmaceutical Retailers subindustry, YSB's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


YSB's Earnings Yield (Joel Greenblatt) % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, YSB's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where YSB's Earnings Yield (Joel Greenblatt) % falls into.



YSB Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

YSBs Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2023 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=-3500.273/3466.7334
=-100.97 %

For company reported semi-annually or annually, GuruFocus only calculate annual data for Earnings Yield (Joel Greenblatt) and apply the annual figure to corresponding quarter.



YSB  (HKSE:09885) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


YSB Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of YSB's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


YSB (HKSE:09885) Business Description

Traded in Other Exchanges
N/A
Address
No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN
YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.
Executives
Chu Mang Yee 2201 Interest of corporation controlled by you
Meta Group Limited 2201 Interest of corporation controlled by you
Sounda Properties Limited 2201 Interest of corporation controlled by you
Shenzhen Songhe International Capital Management Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. 2101 Beneficial owner
Shanghai Fosun Pharmaceutical (group) Co., Ltd. 2201 Interest of corporation controlled by you
Shanghai Fosun High Technology (group) Co., Ltd. 2201 Interest of corporation controlled by you
Chen Xiaohong 2201 Interest of corporation controlled by you
H Capital V Gp, L.p. 2201 Interest of corporation controlled by you
H Capital V Gp, Ltd. 2201 Interest of corporation controlled by you
Guo Guangchang 2201 Interest of corporation controlled by you
Fosun Holdings Limited 2201 Interest of corporation controlled by you
Fosun International Holdings Ltd. 2201 Interest of corporation controlled by you
Fosun International Limited 2201 Interest of corporation controlled by you
Miyt Holdings Limited 2101 Beneficial owner

YSB (HKSE:09885) Headlines

No Headlines